Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001123292-16-001931
Filing Date
2016-03-08
Accepted
2016-03-08 18:38:10
Documents
1
Period of Report
2016-03-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 15215
  Complete submission text file 0001123292-16-001931.txt   16588
Mailing Address 4401 WILSHIRE BLVD. SUITE 200 LOS ANGELES CA 90010
Business Address
ROYSTON IVOR (Reporting) CIK: 0001026765 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37708 | Film No.: 161492900

Mailing Address 460 TOTTEN POND ROAD SUITE 650 WALTHAM MA 02451
Business Address 460 TOTTEN POND ROAD SUITE 650 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Issuer) CIK: 0001395937 (see all company filings)

EIN.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations